Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from european injecting drug users

Journal of Molecular Evolution

Volumn 46, Issue 5, 1998, Pages 602-611

  Salemi, Marco ^a   Vandamme, Anne Mieke ^a   Gradozzi, Chiara ^b   Van Laethem, Kristel ^b   Cattaneo, Ercole ^c   Taylor, Graham ^c   Casoli, Claudio ^d   Goubau, Patrick ^d   Desmyter, Jan ^e   Bertazzoni, Umberto ^e  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF VERONA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

Fixation rate; HTLV II; IIa and IIb subtypes; Maximum likelihood; Molecular clock; Neighbour joining; Parsimony; Phylogenetic analysis; Restriction analysis

Indexed keywords

ARTICLE; GENETIC HETEROGENEITY; HUMAN T CELL LEUKEMIA VIRUS 2; INTRAVENOUS DRUG ADMINISTRATION; LONG TERMINAL REPEAT; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; RESTRICTION MAPPING;

EUROPE; EVOLUTION; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, GENETIC; PHYLOGENY; RESTRICTION MAPPING; SEQUENCE ANALYSIS; SUBSTANCE-RELATED DISORDERS; VARIATION (GENETICS);

EID: 7144227291     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006340     Document Type: Article

References (64)

1. Biglione M, Gessain A, Quiruelas M, Fay O, Taborda MA, Fernandez E, Lupo S, Panzita A, de The G (1993) Endemic HTLV-II infection among Tobas and Matacos Amerindians from North Argentina. J Acquir Immune Defic Syndr 6:631-633
2. Biggar RJ, Buskell-Bales Z, Yakshe PN, Caussy D, Gridley G, Seeff L (1991) Antibody to human retroviruses among drug users in three east-coast American cities. J Infec Dis 163:57-63
3. Black FL, Biggar RJ, Neel JV, Maloney M, Waters DJ (1994) Endemic transmission of HTLV type II among Kayapo Indians of Brazil. AIDS Res Hum Retroviruses 10:1167-1171
4. Britten RJ (1986) Rates of DNA sequence evolution differ between taxonomic groups. Science 231:1393-1398
5. Cimarelli A, Angelin-Duclos C, Gessain A, Casoli C, Bertazzoni U (1996) Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load. Virology 233 (2):362-364
6. Delaporte E, Louwagie J, Peeters M, Monplasir N, D'auriol L, Ville Y, Bedjabaga L, Larouzé B, Vander Grown G, Piot P (1991) Evidence for HTLV-II infection in Central Africa. AIDS 5:771-772
7. De Rossi A, Mammano F, Del Mistro A, Chieco-Bianchi L (1991). Serological and molecular evidence of infection by human T-cell lymphotropic virus type II in Italian drug addicts by use of synthetic peptides and polymerase chain reaction. Eur J Cancer 27:835-838
8. Ehrlich GD, Glaser SB, La Vigne K, Quan D, Mildvan D, Sninsky JJ, Kwo S, Papsidero L, Poiesz BJ (1989) Prevalence of human leukemia/lymphoma virus (HTLV) type II infection among high risk individuals; type-specific identification of HTLVs by polymerase chain reaction. Blood 74:1658-1664
9. Eiraku N, Monken C, Kubo T, Wei Zhu S, Rios M, Bianco C, Hjelle B, Nagashima K, Hall WW (1995) Nucleotide sequence and restriction fragment length polymorphism analysis of the Long Terminal Repeat of human T-cell leukemia virus type II. AIDS Res Hum Retroviruses 11;625-636
10. Eiraku N, Novoa P, Da Costa-Ferreira M et al. (1996) Identification and characterization of a new distinct molecular subtype of human T-cell lymphotropic virus type 2. J Virol 70:1481-1492
11. Felsenstein J (1985) Confidence limits on phytogenies: an approach using the bootstrap. Evolution 39:783-791
12. Felsenstein J (1989) PHYLIP - Phytogeny interference package (Version 3.2). Cladistics 5:164-166
13. Flo RW, Samdal HH, Kalland KH, the Oslo HIV Cohort Study Group, Nilsen A, Haukenes G (1993) Diagnosis of infection with human T-lymphotropic virus type II (HTLV-II) in Norwegian HIV infected individuals. Clin Diagn 1:143-152
14. Froment A, Delaporte E, Dazza MC, Larouzé B (1993) HTLV-II among Pygmies from Cameroon. AIDS Res Hum Retroviruses 9: 707-708
15. Fukushima Y, Takahashi H, Hall WW, Nakasone T, Nakaka S, Song P, Due DD, Hien B, Quang NY, Trinh TN, Nishioka K, Kitamura K, Komuro K, Vahlne A, Honda M (1995) Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res Hum Retroviruses 11:637-644
16. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de Thé G (1985) Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraperesis. Lancet ii:407-409
17. Gessain A, Mauclère P, Froment A, Biglione M, Le Hesran JY, Tekaia F, Millan J, de Thé G (1995) Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), sub-type B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc Natl Acad Sci USA 92:4041-4045
18. Goubau P, Desmyter J, Ghesquiere J, Kasereka B (1992) HTLV-II among pygmies. Nature 359:201
19. Goubau P, Desmyter J, Swanson P, Reynders M, Shih J, Surmont I, Kazadi K, Lee H (1993a) Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides. J Med Virol 39:28-32
20. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter J (1993b) HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res Hum Retroviruses 9:709-713
21. Goubau P, Vandamme A-M, Beuselinck K, Desmiter J (1996) Proviral HTLV-I and HTLV-II in the Efe Pygmies of Northeastern Zaire. J Acquir Immune Defic Syndr 12:208-210
22. Hahn BH, Popovic M, Kalyanaraman VS, et al. (1986a) Detection and characterization of an HTLV-II provirus in a patient with AIDS. In: Gottleib MS, Groopman JE (eds) Acquired immune deficiency syndrome UCLA symposium on molecular and cellular biology, new series. Alan R Riss, New York, 16:73-81
23. Hahn BH, Shaw GM, Taylor ML, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP (1986b) Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548-1535
24. Hall W, Takahashi H, Liu C, Kaplan MH, Scheewind O, Ijichi S (1992) Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol 66:2456-2463
25. Hall WW, Takayuki K, Ijichi S, Takahashi H, Zhu SW (1994) Human T cell leukemia/lymphoma virus, type II (HTLV-II): emergence of an important newly recognized pathogen. Semin Virol 5;165-178
26. Heneine W (1996) The phytogeny and molecular epidemiology of human T-cell lymphotropic virus type II. J Acquir Immune Defic Syndr 13 (Suppl 1):S236-S241
27. Hjelle B, Appenzeller O, Millis R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G (1992) Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645-646
28. Hjelle B, Zhu SW, Takahashi H, Ijichi S, Hall WW (1993) Endemic human T-cell leukemia virus type II infection in Southwestern US Indians involves two prototype variants of virus. J Infect Dis 168: 737-740
29. Huelsenbeck JP, Rannala B (1997) Phylogenetic methods come of age: testing hypotheses in an evolutionary context. Science 276:227-232
30. Ijichi S, Zaninovic V, Leon FE, Katahira Y, Sonoda S, Miura T, Hayami M, Hall WW (1993) Identification of human T-cell leukemia virus type lib infection in the Wayu, an aboriginal population of Colombia. Jpn J Cancer Res 84:1215-1218
31. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC (1982) A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571-573.
32. Kimura M (1980) A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120
33. Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, Engstrom A, Julander I, Käll K, Martin C, Stendahl P, Struve J, Sönnerborg A (1997) Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Human Retrovirology 15:381-386
34. Lairmore MD, Jacobson S, Gracia F, De BK, Castillo L, Larreategui M, Roberts BD, Levine PH, Blattner WA, Kaplan JE (1990) Isolation of human T-cell lymphotropic virus type II from Guaymi Indians in Panama. Proc Natl Acad Sci USA 87:8840-8844
35. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY (1989) High rate of HTLV-II infection in seropositive IV drug abusers from New Orleans. Science 244:471-475
36. Lee H, Idler KB, Swanson P, Aparicio JJ, Chin KK, Lax JP, Nguyen M, Mann T, Leckie G, Zanetti A, Marinucci G, Chen ISY, Rosenblatt JD (1993) Complete nucleotide sequence of HTLV-II isolate NRA. Comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian IV drug users. Virology 196:57-69
37. Levine PH, Jacobson S, Eliot R, Cavallero A, Colclough G, Stephenson C, Knigge RM, Drummond J, Ishimura M, Taylor ME, Wiktor SZ, Shaw G (1993) HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 9:123-128
38. Lin MT, Nguyen BT, Binh TV, Be TV, Chiang TY, Tseng LH, Yang YC, Lin KH, Chen YC (1997) Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients. Arch Virol 142 (7): 1429-1440
39. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw G, Blattner WA (1992) Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 166:100-107
40. Mauclère P, Mahieux R, Garcia-Calleja JM, Salla R, Tekaia F, Millan J, de Thé G, Gessain A (1995) A new HTLV type II subtype A isolate in an HIV type 1-infected prostitute from Cameroon, Central Africa. AIDS Res Hum Retroviruses 11:989-992
41. Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, Nemo G (1997) HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators. Neurology 48(2):315-320
42. Pardi D, Switzer WM, Hadlock KG, Kaplan JE, Lal RB, Folks TM (1993) Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from Guaymi Indian. J Virol 167: 4659-4664
43. Poiesz B, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC, (1980) Detection and isolation of a type C retrovirus particle from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415-7419
44. Poiesz B, Sherman M, Saksena N, Dube D, Dube S, Gavalchin J, Fan N, Lane MJ, Paul B (1993) The biology and epidemiology of the human T-cell lymphoma-leukemia viruses. In: Leu Levvy HC, Weiss (eds) Focus on HIV. Frontiers of infectious diseases. Churchill-Livingston, London
45. Rosenblatt JD, Golde DW, Wachsman W, Giorgi V, Jacobs A, Schmidt G, Quan S, Gasson JC, Chen ISY (1986) A second isolate of HTLV-II associated with atypical cell leukemia. N Engl J Med 315:372-377
46. Salemi M, Cattaneo E, Casoli C, Bertazzoni U (1995) Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr 8:516-520
47. Salemi M, Vandamme A-M, Guano F, Gradozzi C, Cattaneo E, Casoli C, Bertazzoni U (1996) Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of South European epidemics. J Gen Virol 77:1193-1201
48. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, vol 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p E3
49. Soriano V, Calderon E, Esparza B et al. (1993) HTLV-I/II infection in Spain. Int J Epidemiol 22:716-719
50. Shimotohno K, Takahashi Y, Shimizu N, Gojobori T, Golde DW, Chen ISY, Miwa M, Sugimura T (1985) Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci USA 82:3101-3105
51. Switzer WM, Owen SM, Pieniazek D, Nerurkar V, Duenas-Barajas E, Heneine W, Lal RB (1995a) Molecular analysis of human T-cell lymphotropic virus stype II from Wayu indians of Colombia demonstrates two subtypes of HTLV-IIb. Virus Genes 10:153-162
52. Switzer WM, Pieniazek D, Swanson P, Samdal HH, Soriano V, Khabbaz RF, Kaplan JE, Lal RB, Heneine W (1995b) Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 69:621-632
53. Switzer WM, Black FL, Pieniazek D, Biggar RJ, Lal RB, Heneine W (1996) Endemicity and phytogeny of the human T-cell lymphotropic virus type II subtype a from the Kayapo Indians of Brazil: evidence for a limited regional dissemination. AIDS Res Hum Retroviruses 12:635-9
54. Takahashi H, Zhu SH, Ijichi S, Vahlne A, Suzuki H, Hall WW (1993) Nucleotide sequence analysis of human T-cell leukemia virus, type II (HTLV-II) isolates. AIDS Res Hum Retroviruses 9:721-732
55. Tuppin P, Gessain A, Kazanji M, Mahieux R, Cosnefroy JY, Tekai F, Georges-Courbot MC, Georges A, de The G (1996) Evidence for mother to child and sexual transmission of a molecular variant of human T-lymphotropic virus type II, subtype b, within a family in Gabon, Central Africa. J Med Virol 48:22-32
56. Vallejo A, Garcia-Saiz A (1994) Isolation and nucleotide sequence analysis of human T-cell lymphotropic virus type II in Spain. J Acquir Immune Defic Syndr 7:517-519
57. Vallejo A, Ferrante P, Soriano V, Calabrò ML, Mancuso R, Heredia A, Mannella E, Favero A, Garcia-Saiz A, Chieco-Bianchi L, Gonzalez-Lahoz J, Hewlett IK (1997) Nucleotide sequence and RFLP analysis of HTLV-II in Southern Europe. Evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr 13:384-391
58. Vandamme AM, Liu HF, Van Brussel M, De Meurichy W, Desmyter J, Goubau P (1996) The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the Human T-lymphotropic/simian T-lymphotropic group of viruses. J Gen Virol 77:1089-1099
59. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P (1997) Use of a generic PCR assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serologies. J Med Virol 52:1-7
60. Wattel E, Cavrois M, Gessain A, Wain-Hobson S (1996) Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr 13 (Suppl 1):S92-S99
61. Weaver S, Scott TW, Rico-Hesse R (1991) Molecular evolution of eastern equine encephalomyelitis virus in North America. Virology 182:774-784
62. Weissmann C, Weber H (1986) The Interferon genes. Prog Nucleic Acid Res Mol Biol 33:251-301
63. Zella D, Cavicchini A, Salemi M, Casoli C, Lori F, Achilli G, Cattaneo E, Landini V, Bertazzoni U (1993) Molecular characterization of two isolates of human T cell leukemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 74:437-444
64. Zella D, Mori L, Sala M, Ferrante P, Casoli C, Magnani G, Achilli G, Cattaneo E, Lori F, Bertazzoni U (1990) HTLV-II infection in Italian drug abusers. Lancet 335:575-576